A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden

Clinical trial NCT07721259 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07721259
Sponsor: University of Washington
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Triple-Negative Breast Carcinoma

Start date: 2026-09-30
Primary completion: 2029-07-16
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.